Benzinga''s Top Ratings Upgrades, Downgrades For May 25, 2022 Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ: MOLN ) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of $5.92. Molecular Partners closed at $6.88 at the end of the last trading period. Mizuho upgraded the previous rating for Sabra Health Care REIT Inc (NASDAQ: SBRA ) from Neutral to Buy. For the first quarter, Sabra Health Care REIT had an EPS of $0.38, compared to year-ago quarter EPS of $0.39. The stock has a 52-week-high of $19.02 and a 52-week-low of $11.44. At the end of the last trading period, Sabra Health Care REIT closed at $13.37. According to JP Morgan, the prior rating for Magellan Midstream Partners LP (NYSE: MMP ) was changed from Neutral to Overweight. In the first quarter, Magellan Midstream showed an EPS of $1.10, compared to $1.09 from the year-ago quarter. The stock has a 52-week-high of $53.85 and a 52-week-low of $43.58. At the end of the last trading period, Magellan Midstream closed at $48.83.